Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | MMP1 | P03956 | 1/20 | 0.34 |
| ▸ | MMP2 | P08253 | 1/20 | 0.34 |
| ▸ | MMP3 | P08254 | 1/20 | 0.34 |
| ▸ | MMP9 | P14780 | 1/20 | 0.34 |
| ▸ | MMP8 | P22894 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16900173 | 0.85 | — | — | |
| SCHEMBL10106480 | 0.83 | ALDH1A1 (0.41) | ALDH1A1GAAMMP1MMP2MMP3 | |
| SCHEMBL4405423 | 0.80 | ALDH1A1 (0.48) | ALDH1A1GAAMMP1MMP2MMP3 | |
| SCHEMBL10068166 | 0.79 | ALDH1A1 (0.44) | ALDH1A1GAAMMP1MMP2MMP3 | |
| SCHEMBL10106382 | 0.77 | THRB (0.44) | ALDH1A1 | |
| SCHEMBL8413747 | 0.76 | CHRM1 (0.40) | ALDH1A1 | |
| SCHEMBL18381052 | 0.76 | ALDH1A1 (0.35) | ALDH1A1GAAMMP1MMP2MMP3 | |
| SCHEMBL6682335 | 0.74 | ALDH1A1 (0.44) | ALDH1A1GAAMMP1MMP2MMP3 | |
| SCHEMBL10060080 | 0.73 | THRB (0.47) | ALDH1A1GAA | |
| SCHEMBL12016262 | 0.72 | ALDH1A1 (0.42) | ALDH1A1GAAMMP1MMP2MMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9079828-B2 | Polymerizable compounds comprising a polyalicylic structure element | VOCO GMBH (DE) | 2015-07-14 | — | — | US | disclosed |
| US-20120082959-A1 | Polymerizable Compounds Comprising a Polyalicylic Structure Element | VOCO GMBH (DE) | 2012-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120082959-A1 | Polymerizable Compounds Comprising a Polyalicylic Structure Element | PCBP1, PUF60, PARG | ALDH1A1 3882/4885GAA 427/4885MMP1 4530/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.